Evidence map›Paper›PMID 41479834›Full record

ReviewWorld journal of nephrology2025

Lung ultrasound in nephrology: Basics, applications, limitations, and future directions.

Naga Sai Akhil Reddy Gogula, Abhilash Koratala

Abstract readReview
In one paragraph

Review in World journal of nephrology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Naga Sai Akhil Reddy GogulaMolecular Physiology Institute, Duke University School of Medicine, Durham, NC 27710, United States.
Abhilash KoratalaDivision of Nephrology, Medical College of Wisconsin, Milwaukee, WI 53226, United States. akoratala@mcw.edu.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Point-of-care ultrasonography (POCUS) is increasingly recognized as a valuable extension of the physical exam, offering real-time bedside insights to support clinical decision-making. In nephrology, lung ultrasound (LUS) is gaining prominence for its ability to assess extravascular lung water and guide fluid management, especially in patients with end-stage renal disease. This narrative review highlights current applications, technical aspects, and limitations of LUS in nephrology. Studies such as the Lung Water by Ultrasound-Guided Treatment in Haemodialysis Patients trial indicate that LUS-guided ultrafiltration may help improve blood pressure control, reduce pulmonary congestion and acute heart failure events in dialysis patients. Simplified approaches like the 8-zone protocol have shown diagnostic accuracy comparable to the traditional 28-zone method, improving feasibility in clinical practice. Nonetheless, limitations exist, including reduced specificity in non-cardiogenic lung conditions and under recognition of right-sided congestion when used in isolation. A comprehensive hemodynamic assessment requires integrating LUS with inferior vena cava ultrasound, focused cardiac ultrasound, and venous Doppler. Successful implementation depends on structured training and an understanding of potential interpretation challenges. Looking ahead, streamlined protocols, multimodal integration, and standardized training will be key to establishing POCUS as a core tool in nephrology.

Indexed as

B-linesDialysisHeart failureNephrologyPoint-of-care ultrasonographyUltrasound

Identifiers

PMID41479834
PMCPMC12754413

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.